FHBC-porphyrin hybrid 6
32.1, 32.2, 35.0, 35.1 (2), 41.0, 55.8, 119.0 (2), 119.4, 120.5, 120.6
(2), 120.7 (2), 120.8, 120.9 (2), 122.0, 122.8, 123.6, 124.8, 125.3,
127.3, 128.2 (2), 128.9, 129.0 (2), 130.8, 131.5 (3), 131.6 (2), 131.7,
132.4, 139.2, 140.6, 141.1, 141.4, 141.6, 141.7, 141.8, 141.9, 142.0,
148.6, 148.9, 149.0, 149.2, 150.0, 150.6, 151.2, 152.3, 152.5, 152.6.
MALDI-TOF (m/z): 3749.7 ([M + H]+ requires 3749.1).
Compound 4 (120 mg, 0.08 mmol), bromoquinoxalinoporphyrin
5 (200 mg, 0.16 mmol) and Pd(PPh3)4 (1 mg) were dissolved in
degassed toluene (5 mL). Tetraethylammonium hydroxide
solution (20% wt. in water, 2 mL) was thoroughly degassed
and added to the reaction mixture. The resulting solution was
heated at 90 ꢂC for 14 h and the product was extracted into
toluene. The toluene solution was dried over Na2SO4 and filtered
through a plug of silica. After the removal of toluene, the
resulting residue was purified by size exclusion chromatogra-
phy (Bio-Rad, Bio-Beads S-X1, THF) and a brownish purple
solid (150 mg, 68% yield) was obtained after precipitation
from methanol. m.p. >250 ꢂC. Elemental analysis: calcd. for
{5,10,15,20-Tetrakis(3,5-di-tert-butylphenyl)-60-
bromoquinoxalino[2,3–b0]porphyrinato}zinc(II) – Zinc(II) Bromo-
quinoxalinoporphyrin 5-Zn
A
solution of 5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)-60-
bromoquinoxalino[2,3–b0]porphyrin 5 (400 mg, 0.321 mmol) and
zinc(II) acetate dihydrate (735 mg, 3.349 mmol) in chloroform (40
mL) and methanol (20 mL) was heated at reflux for 30 min. The
solvent was removed under vacuum and the residue purified by
column chromatography over silica (dichloromethane/light
petroleum; 1 : 1). The front running green band was collected
and the solvent removed to give {5,10,15,20-tetrakis(3,5-di-tert-
butylphenyl)-60-bromoquinoxalino[2,3–b0]porphyrinato}zinc(II)
5-Zn (419 mg, 99%) as a dark green microcrystalline solid, mp >
C264H286N12, C 87.4, H 8.0, N 4.6; found C 86.5, H 8.1, N 4.1.
FT-IR (neat, cmꢁ1): 2959, 2925, 2859, 1593, 1470, 1363, 1248,
801, 759. UV-Vis: lmax, nm (3, ꢀ 105 Mꢁ1 cmꢁ1) ¼ 366 (2.1), 439
(4.6). 1H NMR (500 MHz, CDCl3, 3 mM, 20 ꢂC, d): ꢁ2.43 (s, 4H,
porphyrin NH), 0.81 (br m, 12H, octyl-CH3), 1.28–1.41 (br m,
48H, –CH2–), 1.54 (s, 72H, t-butyl), 1.56 (s, 36H, t-butyl), 1.63
(s, 36H, t-butyl), 2.49–2.62 (m, 8H, –CH2–), 7.69 (br, 4H,
HBC–H), 7.83 (m, 4H, ArH), 7.98–8.16 (m, 34H, ArH), 8.31
(br s, 4H, ArH), 8.40 (br, 4H, HBC–H), 8.58 (br, 4H, HBC–H),
8.76 (br, 4H, HBC–H), 8.82 (s, 4H, ArH), 9.03 (br m, 4H,
porphyrin-H), 9.12 (br m, 2H, porphyrin-H), 9.17 (br m, 2H,
porphyrin-H). 13C NMR (125 MHz, CDCl3, 20 ꢂC, d): 14.2, 21.5,
22.8, 24.6, 29.5, 29.7, 29.8, 30.7, 31.7(2), 31.8, 31.9, 32.0 (2), 32.2,
35.0, 35.1 (2), 35.2, 41.1, 55.8, 118.3, 118.8, 119.4, 120.7, 120.9,
121.1, 122.1, 122.8, 123.6, 125.3, 126.5, 127.1, 127.8, 128.2, 128.5,
129.0, 129.3, 129.6, 130.9, 132.4, 132.6, 134.2, 137.8, 138.2, 139.4,
139.6, 139.7, 140.4, 141.2, 141.9, 146.1, 146.2, 148.8, 149.0, 149.1,
152.1, 152.3, 152.8, 153.4, 155.0. HR-MALDI-TOF (m/z): found
[M + H]+ 3625.4400, C264H286N12 requires 3625.2821.
ꢂ
300 C. An analytically pure sample was obtained by recrystal-
lisation from a chloroform–methanol solution. (HR-ESI-FT/
ICR Found: [M + H]+ 1305.5979. C82H94BrN6Zn requires
1305.6009). nmax (CHCl3): 2962s, 2932s, 2901s, 2870m, 1589s,
1543w, 1474m, 1427w, 1358w, 1296w, 1250w, 1157w, 1126w,
1003w cmꢁ1. lmax (CHCl3): 342 (log 3 4.51), 361sh (4.41), 422
(5.32), 451 (5.08), 540 (3.93), 575 (4.32), 620 (4.22), 801 (2.70) nm.
1H NMR (400 MHz, CDCl3): d 1.47 (18 H, s, t-butyl H); 1.49 (18
H, s, t-butyl H); 1.53 (36 H, s, t-butyl H); 7.75 (1 H, d, J 9.0 Hz,
quinoxaline H); 7.79 (2 H, t, J 1.8 Hz, Hp); 7.85 (1 H, d of d, J 8.9,
J 2.2 Hz, quinoxaline H); 7.91 (1 H, t, J 1.8 Hz, Hp); 7.94–7.95 (5
H, d overlapped with t, Ho, Hp); 8.06 (1 H, d, J 2.1 Hz, qui-
noxaline H); 8.09 (4 H, d, J 1.8 Hz, Ho); 8.91 (2 H, s, b-pyrrolic
H); 9.00 (2 H, d, J 4.7 Hz, b-pyrrolic H); 9.03–9.05 (2 H, m, b-
pyrrolic H). Mass spectrum (ESI) (m/z): 1305.7 ([M + H]+
requires 1305.6).
FHBC–Zn-porphyrin hybrid 6-Zn
Compound 4 (120 mg, 0.08 mmol), bromoquinoxalino Zn-
porphyrin 5-Zn (210 mg, 0.16 mmol) and Pd(PPh3)4 (1 mg) were
dissolved in degassed THF (10 mL). An aqueous solution of
NaHCO3 (100 mg in 2 mL) was thoroughly degassed and added
to the reaction mixture. The resulting solution was heated at
Photovoltaic device fabrication and testing
Poly(3,4-ethylenedioxythiophene) : poly(styrenesulfonate)
ꢂ
60 C for 14 h and the product was extracted into toluene. The
(PEDOT:PSS, Baytron P AI 4083) was spin coated (5000 rpm)
on patterned ITO glass which was washed by detergent, deion-
ized water, methanol, acetone and 2-propanol in ultrasonication
bath and UV/ozone treated. The films were baked at 150 ꢂC for 5
min in air. Solution of FHBC compounds and PC61BM (25 mg
mLꢁ1) were prepared in chlorobenzene separately. The solution
was stirred at 60 ꢂC for 2 h and cooled down to room tempera-
ture before they were mixed together. Blend solutions (donor–
acceptor 1 : 2) were made by mixing appropriate volumes of the
solutions. The resulting solutions were stirred for 30 min and spin
coated (1500 rpm) on the PEDOT:PSS films. TiOx precursor
solution (1 : 200 in methanol) was deposited on the active layer
by spin coating (2000 rpm) to form ꢃ10 nm of TiOx layer. The
films were exposed to air for about 20 min at room temperature
for hydrolysis or baked at 150 ꢂC for 15 s (total air exposure time
was about 10 min). The films were transferred to a metal evap-
oration chamber and aluminium (100 nm) was deposited through
a shadow mask (active area was 0.20 cm2) at approximately 1 ꢀ
toluene solution was dried over Na2SO4 and filtered through
a plug of silica. After the removal of toluene, the resulting residue
was purified by size exclusion chromatography (Bio-Rad,
Bio-Beads S-X1, THF) and a greenish purple solid (100 mg,
35% yield) was obtained after precipitation from methanol.
m.p. >250 ꢂC. Elemental analysis: calcd. for C264H282N12Zn2,
C 84.5, H 7.6, N 4.5, Zn 3.5; found C 82.4, H 7.8, N 4.1. FT-IR
(neat, cmꢁ1): 2961, 2923, 2854, 1591, 1467, 1259, 1088, 1016, 796.
UV-Vis: lmax, nm (3, ꢀ 105 Mꢁ1 cmꢁ1) ¼ 366 (2.9), 421 (2.8), 448
1
ꢂ
(2.3). H NMR (500 MHz, CDCl3, 20 C, d): 0.81 (br m, 12H,
octyl-CH3), 1.27–1.41 (br m, 48H, –CH2–), 1.56 (br s, 108H,
t-butyl), 1.64 (s, 36H, t-butyl), 2.45–2.61 (m, 8H, –CH2–), 7.47–
7.59 (br m, 8H, Ar–H), 7.83 (m, 4H, ArH), 8.01–8.14 (m, 34H,
ArH), 8.39–8.58 (br s, 16H, ArH), 8.95 (s, 4H, ArH), 9.06 (br m,
4H, porphyrin-H), 9.12 (br m, 2H, porphyrin-H), 9.16 (br m, 2H,
porphyrin-H). 13C NMR (125 MHz, CDCl3, 20 ꢂC, d): 14.1, 22.7,
24.5, 29.5 (2), 29.6, 29.7, 30.4, 30.6, 31.4, 31.4, 31.5 (2), 31.8, 31.9,
This journal is ª The Royal Society of Chemistry 2010
J. Mater. Chem., 2010, 20, 7005–7014 | 7013